Table of Content

Table of Contents

Global Radiopharmaceutical (Oral Route) Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Radiopharmaceutical (Oral Route) Market by Value
2.2.1 Global Radiopharmaceutical (Oral Route) Revenue by Type
2.2.2 Global Radiopharmaceutical (Oral Route) Market by Value (%)
2.3 Global Radiopharmaceutical (Oral Route) Market by Production
2.3.1 Global Radiopharmaceutical (Oral Route) Production by Type
2.3.2 Global Radiopharmaceutical (Oral Route) Market by Production (%)

3. The Major Driver of Radiopharmaceutical (Oral Route) Industry
3.1 Historical & Forecast Global Radiopharmaceutical (Oral Route) Demand
3.2 Largest Application for Radiopharmaceutical (Oral Route) (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Radiopharmaceutical (Oral Route) Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Radiopharmaceutical (Oral Route) Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Radiopharmaceutical (Oral Route) Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Radiopharmaceutical (Oral Route) Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Radiopharmaceutical (Oral Route) Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Radiopharmaceutical (Oral Route) Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Radiopharmaceutical (Oral Route) Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Radiopharmaceutical (Oral Route) Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Radiopharmaceutical (Oral Route) Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Radiopharmaceutical (Oral Route) Average Price Trend
12.1 Market Price for Each Type of Radiopharmaceutical (Oral Route) in US (2018-2022)
12.2 Market Price for Each Type of Radiopharmaceutical (Oral Route) in Europe (2018-2022)
12.3 Market Price for Each Type of Radiopharmaceutical (Oral Route) in China (2018-2022)
12.4 Market Price for Each Type of Radiopharmaceutical (Oral Route) in Japan (2018-2022)
12.5 Market Price for Each Type of Radiopharmaceutical (Oral Route) in India (2018-2022)
12.6 Market Price for Each Type of Radiopharmaceutical (Oral Route) in Korea (2018-2022)
12.7 Market Price for Each Type of Radiopharmaceutical (Oral Route) in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Radiopharmaceutical (Oral Route) Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Radiopharmaceutical (Oral Route)

14. Radiopharmaceutical (Oral Route) Competitive Landscape
14.1 Bracco Imaging
14.1.1 Bracco Imaging Company Profiles
14.1.2 Bracco Imaging Product Introduction
14.1.3 Bracco Imaging Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Bayer
14.2.1 Bayer Company Profiles
14.2.2 Bayer Product Introduction
14.2.3 Bayer Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Mallinckrodt
14.3.1 Mallinckrodt Company Profiles
14.3.2 Mallinckrodt Product Introduction
14.3.3 Mallinckrodt Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Nordion
14.4.1 Nordion Company Profiles
14.4.2 Nordion Product Introduction
14.4.3 Nordion Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Triad Isotopes
14.5.1 Triad Isotopes Company Profiles
14.5.2 Triad Isotopes Product Introduction
14.5.3 Triad Isotopes Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Lantheus
14.6.1 Lantheus Company Profiles
14.6.2 Lantheus Product Introduction
14.6.3 Lantheus Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 IBA Group
14.7.1 IBA Group Company Profiles
14.7.2 IBA Group Product Introduction
14.7.3 IBA Group Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 GE Healthcare
14.8.1 GE Healthcare Company Profiles
14.8.2 GE Healthcare Product Introduction
14.8.3 GE Healthcare Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 China Isotope & Radiation
14.9.1 China Isotope & Radiation Company Profiles
14.9.2 China Isotope & Radiation Product Introduction
14.9.3 China Isotope & Radiation Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Jubilant Pharma
14.10.1 Jubilant Pharma Company Profiles
14.10.2 Jubilant Pharma Product Introduction
14.10.3 Jubilant Pharma Radiopharmaceutical (Oral Route) Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Eli Lilly
14.12 Advanced Accelerator Applications
14.13 SIEMENS
14.14 Dongcheng
14.15 Navidea
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Radiopharmaceutical (Oral Route) Industry (Volume)
Figure 2. Radiopharmaceutical (Oral Route) Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Radiopharmaceutical (Oral Route) Revenue in 2022
Figure 5. US Radiopharmaceutical (Oral Route) Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Radiopharmaceutical (Oral Route) Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Radiopharmaceutical (Oral Route) Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Radiopharmaceutical (Oral Route) Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Radiopharmaceutical (Oral Route) Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Radiopharmaceutical (Oral Route) Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Radiopharmaceutical (Oral Route) Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Radiopharmaceutical (Oral Route) Revenue, by Type (Million USD) (2018-2028)
Table 4. Radiopharmaceutical (Oral Route) Production, by Type (K Unit) (2018-2028)
Table 5. Radiopharmaceutical (Oral Route) Demand (K Unit) by Application (2018-2028)
Table 6. Radiopharmaceutical (Oral Route) Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Radiopharmaceutical (Oral Route) Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Radiopharmaceutical (Oral Route) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Radiopharmaceutical (Oral Route) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Radiopharmaceutical (Oral Route) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Radiopharmaceutical (Oral Route) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Radiopharmaceutical (Oral Route) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Radiopharmaceutical (Oral Route) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Radiopharmaceutical (Oral Route) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Radiopharmaceutical (Oral Route) in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Radiopharmaceutical (Oral Route) in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Radiopharmaceutical (Oral Route) in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Radiopharmaceutical (Oral Route) in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Radiopharmaceutical (Oral Route) in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Radiopharmaceutical (Oral Route) in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Radiopharmaceutical (Oral Route) in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Bracco Imaging Profiles
Table 61. Bracco Imaging Radiopharmaceutical (Oral Route) Product Introduction
Table 62. Bracco Imaging Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Bracco Imaging Strategic initiatives
Table 64. Bayer Profiles
Table 65. Bayer Radiopharmaceutical (Oral Route) Product Introduction
Table 66. Bayer Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Bayer Strategic initiatives
Table 68. Mallinckrodt Profiles
Table 69. Mallinckrodt Radiopharmaceutical (Oral Route) Product Introduction
Table 70. Mallinckrodt Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Mallinckrodt Strategic initiatives
Table 72. Nordion Profiles
Table 73. Nordion Radiopharmaceutical (Oral Route) Product Introduction
Table 74. Nordion Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Nordion Strategic initiatives
Table 76. Triad Isotopes Profiles
Table 77. Triad Isotopes Radiopharmaceutical (Oral Route) Product Introduction
Table 78. Triad Isotopes Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Triad Isotopes Strategic initiatives
Table 80. Lantheus Profiles
Table 81. Lantheus Radiopharmaceutical (Oral Route) Product Introduction
Table 82. Lantheus Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Lantheus Strategic initiatives
Table 84. IBA Group Profiles
Table 85. IBA Group Radiopharmaceutical (Oral Route) Product Introduction
Table 86. IBA Group Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. IBA Group Strategic initiatives
Table 88. GE Healthcare Profiles
Table 89. GE Healthcare Radiopharmaceutical (Oral Route) Product Introduction
Table 90. GE Healthcare Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. GE Healthcare Strategic initiatives
Table 92. China Isotope & Radiation Profiles
Table 93. China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Introduction
Table 94. China Isotope & Radiation Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. China Isotope & Radiation Strategic initiatives
Table 97. Jubilant Pharma Profiles
Table 98. Jubilant Pharma Radiopharmaceutical (Oral Route) Product Introduction
Table 99. Jubilant Pharma Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Jubilant Pharma Strategic initiatives
Table 101. Eli Lilly Profiles
Table 102. Eli Lilly Radiopharmaceutical (Oral Route) Product Introduction
Table 103. Eli Lilly Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Eli Lilly Strategic initiatives
Table 105. Advanced Accelerator Applications Profiles
Table 106. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Introduction
Table 107. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Advanced Accelerator Applications Strategic initiatives
Table 109. SIEMENS Profiles
Table 110. SIEMENS Radiopharmaceutical (Oral Route) Product Introduction
Table 111. SIEMENS Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. SIEMENS Strategic initiatives
Table 113. Dongcheng Profiles
Table 114. Dongcheng Radiopharmaceutical (Oral Route) Product Introduction
Table 115. Dongcheng Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Dongcheng Strategic initiatives
Table 117. Navidea Profiles
Table 118. Navidea Radiopharmaceutical (Oral Route) Product Introduction
Table 119. Navidea Radiopharmaceutical (Oral Route) Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Navidea Strategic initiatives